Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Diabetic Macular Edema (DR-002)
NCT00656643Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Jun 2008
- Primary completion
- Nov 2009
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in diabetic macular edema (DME), sponsored by Santen Pharmaceutical. Started Jun 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00656643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656643.